Theravance Biopharma
TBPH
#6934
Rank
A$0.69 B
Marketcap
Country
$14.14
Share price
-2.66%
Change (1 day)
-0.05%
Change (1 year)

Theravance Biopharma (TBPH) - Total debt

Total debt on the balance sheet as of December 2024 : A$80.29 Million

According to Theravance Biopharma 's latest financial reports the company's total debt is A$80.29 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Theravance Biopharma - Total debt on balance sheet (from 2016 to 2024)

Total debt by year

Year Total debt Change
2024-12-31A$80.09 M11.01%
2023-12-31A$72.15 M-5.86%
2022-12-31A$76.64 M-91.7%
2021-12-31A$0.92 B5.01%
2020-12-31A$0.87 B20.61%
2019-12-31A$0.72 B13.06%
2018-12-31A$0.64 B125.04%
2017-12-31A$0.28 B-7.23%
2016-12-31A$0.30 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$1.38 B 1,624.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.17 M-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.13 M-93.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.97 B 9,829.75%๐Ÿ‡บ๐Ÿ‡ธ USA